These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21446406)

  • 1. Overcoming multidrug resistance of breast cancer cells by the micellar doxorubicin nanoparticles of mPEG-PCL-graft-cellulose.
    Chen CH; Cuong NV; Chen YT; So RC; Liau I; Hsieh MF
    J Nanosci Nanotechnol; 2011 Jan; 11(1):53-60. PubMed ID: 21446406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-sized micelles of block copolymers of methoxy poly(ethylene glycol)-poly(epsilon-caprolactone)-graft-2-hydroxyethyl cellulose for doxorubicin delivery.
    Hsieh MF; Cuong NV; Chen CH; Chen YT; Yeh JM
    J Nanosci Nanotechnol; 2008 May; 8(5):2362-8. PubMed ID: 18572650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery.
    Shuai X; Ai H; Nasongkla N; Kim S; Gao J
    J Control Release; 2004 Aug; 98(3):415-26. PubMed ID: 15312997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells.
    Wang YC; Wang F; Sun TM; Wang J
    Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
    Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D
    Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of particle morphology of pH-dependent poly(epsilon-caprolactone)-poly(gamma-glutamic acid) micellar nanoparticles to combat breast cancer cells.
    Chan AS; Chen CH; Huang CM; Hsieh MF
    J Nanosci Nanotechnol; 2010 Oct; 10(10):6283-97. PubMed ID: 21137721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.
    Zhang J; Men K; Gu Y; Wang X; Gou M; Guo G; Luo F; Qian Z
    J Nanosci Nanotechnol; 2011 Jun; 11(6):5054-61. PubMed ID: 21770143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
    Guo Y; Chu M; Tan S; Zhao S; Liu H; Otieno BO; Yang X; Xu C; Zhang Z
    Mol Pharm; 2014 Jan; 11(1):59-70. PubMed ID: 24229050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
    Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of hydrophilic and hydrophobic drugs by micelles: a new approach using drug conjugated PEG-PCLNanoparticles.
    Danafar H; Rostamizadeh K; Davaran S; Hamidi M
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1908-1918. PubMed ID: 28737462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diselenide linkage containing triblock copolymer nanoparticles based on Bi(methoxyl poly(ethylene glycol))-poly(ε-carprolactone): Selective intracellular drug delivery in cancer cells.
    Hailemeskel BZ; Hsu WH; Addisu KD; Andrgie AT; Chou HY; Lai JY; Tsai HC
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109803. PubMed ID: 31349440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
    Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
    [No Abstract]   [Full Text] [Related]  

  • 18. mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer.
    Wang S; Chen R; Morott J; Repka MA; Wang Y; Chen M
    Expert Opin Drug Deliv; 2015 Mar; 12(3):361-73. PubMed ID: 25392124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells.
    Danafar H; Sharafi A; Kheiri Manjili H; Andalib S
    Pharm Dev Technol; 2017 Aug; 22(5):642-651. PubMed ID: 26916923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers.
    Huang W; Lang Y; Hakeem A; Lei Y; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1723-1736. PubMed ID: 29606866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.